首页> 外文期刊>Journal of cellular and molecular medicine. >Personalized application of three different concentrations of iodinated contrast media in coronary computed tomography angiography
【24h】

Personalized application of three different concentrations of iodinated contrast media in coronary computed tomography angiography

机译:三种不同浓度碘化对比介质在冠状动脉计算机断层造影血管造影中的个性化应用

获取原文
           

摘要

No study has evaluated the impact of different iodinated contrast media on coronary contrast enhancement, using an injection protocol according to body surface area (BSA). Thus, the present study aimed to examine the usefulness and safety of personalized application of different iodine concentrations of contrast media in coronary computed tomographic (CT) angiography with a 2nd dual‐source CT scanner in eliminating differences in coronary contrast enhancement based on a BSA‐adapted injection protocol of contrast media. A total of 270 enrolled participants were randomly assigned to three groups: ioversol 320, ioversol 350 and iopromide 370 (n?=?90 per group). The three groups were administered contrast media at a BSA‐adjusted volume and flow rate with a fixed injection time of 15?seconds, and they subsequently received a 30‐mL saline flush. All patients were scanned with a prospective electrocardiogram‐gated protocol in a craniocaudal direction using a second‐generation 128‐slice dual‐source CT system. The three iodinated contrast media used in coronary CT angiography exhibited similar diagnostic quality and safety. No significant differences were found in the contrast enhancement degrees, image quality scores, radiation doses and incidences of adverse effects among the three groups. The three contrast media used in coronary CT angiography with 320, 350 and 370?mg/mL iodine, respectively, have comparable diagnostic quality and safety. However, more large‐scale, multinational, multi‐centre and prospective trials are warranted.
机译:没有研究通过根据体表面积(BSA)的注射方案评估了不同碘化对比介质对冠状动脉对比度增强的影响。因此,本研究旨在研究不同碘浓度对造影剂中造影剂(CT)血管造影的不同碘浓度的有用性和安全性,其利用第二双源CT扫描仪消除基于BSA的冠状动脉对比增强的差异适应对比介质的注射方案。共有270名注册的参与者被随机分配到三组:碘醇320,碘醇350和IOPROMIDE 370(每组N?= 90)。在BSA调节的体积和流速下施用三组造影剂,其固定喷射时间为15?秒,随后接受30ml盐水冲洗。使用第二代128切片双源CT系统,用颅内通道的前瞻性心电图介绍所有患者扫描所有患者。冠状动脉CT血管造影中使用的三种碘造影剂表现出类似的诊断质量和安全性。在对比增强度,图像质量评分,辐射剂量和三组不良反应的情况下没有发现显着差异。冠状动脉CT血管造影的三种造影剂,分别具有320,350和370×mg / ml碘,具有可比的诊断质量和安全性。但是,有权更加大规模,跨国公司,多中心和预期试验。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号